Transformation and new ways of working – the buzzwords that you hear a lot these days applied to business or IT functions. Are these concepts also suitable for finance, and especially finance in a stock listed large corporation? This article will describe this transformation and also outline the main success factors.
Svenja Amrhein
Svenja Amrhein is the Global Head of Finance, Pharma Research & Early Development at Roche. Roche is the world’s largest biotech company and a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.
Throughout Svenja’s 10+ years with Roche, she held various finance roles at the headquarters in Basel and affiliates, most recently in Sweden. Svenja is passionate about understanding the full value chain and bringing these insights to the table during conversations with business partners.
Her strength is developing individuals to bring their full potential to work and inspiring teams to be truly value-adding partners to their customers.
+
Subscribe to
FP&A Trends Digest
We will regularly update you on the latest trends and developments in FP&A. Take the opportunity to have articles written by finance thought leaders delivered directly to your inbox; watch compelling webinars; connect with like-minded professionals; and become a part of our global community.